Vedere Bio is a biopharmaceutical company that researches and develops ocular gene therapies for the treatment of eye disorders.
Business Model:
Revenue: $3M
Employees: 11-50
Vedere Bio ll was acquired by
Novartis.
The acquisition happend on 2020-10-29.
Details of the transaction were not public
Address: 400 Technology Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Vedere Bio is a biopharmaceutical company that researches and develops ocular gene therapies for the treatment of eye disorders.
Contact Phone:
+18572012700
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2019 | Series A | 3 | $21M |
Foundation Fighting Blindness Atlas Venture Mission BioCapital Atlas Venture Foundation Fighting Blindness Mission BioCapital |
5/2021 | Series A | $0 |
Atlas Venture Casdin Capital Mission BioCapital Octagon Capital Advisors Retinal Degeneration Fund Samsara BioCapital Atlas Venture Casdin Capital Mission BioCapital Octagon Capital Advisors Retinal Degeneration Fund Samsara BioCapital |
5/2021 | Series A | 6 | $77M |
Octagon Capital Samsara BioCapital Casdin Capital Atlas Venture Mission BioCapital the RD Fund Atlas Venture Casdin Capital Mission BioCapital Octagon Capital Advisors Retinal Degeneration Fund Samsara BioCapital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|